Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Wang, P; Anderson, PO; Chen, SW; Paulsson, KM; Sjogren, HO; Li, SL
   Inhibition of the transcription factors AP-1 and NF-kappa B in CD4 T cellsby peroxisome proliferator-activated receptor gamma ligands
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   P. Wang et al., "Inhibition of the transcription factors AP-1 and NF-kappa B in CD4 T cellsby peroxisome proliferator-activated receptor gamma ligands", INT IMMUNO, 1(4), 2001, pp. 803-812
2. Cockcroft, JR; Wilkinson, IB; Yki-Jarvinen, H
   Multiple risk factor intervention in type 2 diabetes: an opportunity not to be missed
   DIABETES OBESITY & METABOLISM
   
   J.R. Cockcroft et al., "Multiple risk factor intervention in type 2 diabetes: an opportunity not to be missed", DIABET OB M, 3(1), 2001, pp. 1-8
3. Herrick, AL; Illingworth, KJ; Hollis, S; Gomez-Zumaquero, JM; Tinahones, FJ
   Antibodies against oxidized low-density lipoproteins in systemic sclerosis
   RHEUMATOLOGY
   
   A.L. Herrick et al., "Antibodies against oxidized low-density lipoproteins in systemic sclerosis", RHEUMATOLOG, 40(4), 2001, pp. 401-405
4. Buechler, C; Ritter, M; Duong, CQ; Orso, E; Kapinsky, M; Schmitz, G
   Adipophilin is a sensitive marker for lipid loading in human blood monocytes
   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
   
   C. Buechler et al., "Adipophilin is a sensitive marker for lipid loading in human blood monocytes", BBA-MOL C B, 1532(1-2), 2001, pp. 97-104
5. Sidhu, JS; Kaski, JC
   Peroxisome proliferator activated receptor gamma: a potential therapeutic target in the management of ischaemic heart disease
   HEART
   
   J.S. Sidhu e J.C. Kaski, "Peroxisome proliferator activated receptor gamma: a potential therapeutic target in the management of ischaemic heart disease", HEART, 86(3), 2001, pp. 255-258
6. Chrysselis, MC; Rekka, EA; Kourounakis, PN
   Antioxidant therapy and cardiovascular disorders
   EXPERT OPINION ON THERAPEUTIC PATENTS
   
   M.C. Chrysselis et al., "Antioxidant therapy and cardiovascular disorders", EXPERT OP T, 11(1), 2001, pp. 33-43
7. Duez, H; Fruchart, JC; Staels, B
   PPARs in inflammation, atherosclerosis and thrombosis
   JOURNAL OF CARDIOVASCULAR RISK
   
   H. Duez et al., "PPARs in inflammation, atherosclerosis and thrombosis", J CARD RISK, 8(4), 2001, pp. 187-194
8. Mendy, FO
   Functionality, resilience, maintenance and polyunsaturated fatty acids
   OCL-OLEAGINEUX CORPS GRAS LIPIDES
   
   F.O. Mendy, "Functionality, resilience, maintenance and polyunsaturated fatty acids", OCL-OL CORP, 8(4), 2001, pp. 321-327
9. Chawla, A; Boisvert, WA; Lee, CH; Laffitte, BA; Barak, Y; Joseph, SB; Liao, D; Nagy, L; Edwards, PA; Curtiss, LK; Evans, RM; Tontonoz, P
   A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
   MOLECULAR CELL
   
   A. Chawla et al., "A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis", MOL CELL, 7(1), 2001, pp. 161-171
10. Natarajan, R; Reddy, MA; Malik, KU; Fatima, S; Khan, BV
    Signaling mechanisms of nuclear factor-kappa B-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    R. Natarajan et al., "Signaling mechanisms of nuclear factor-kappa B-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells", ART THROM V, 21(9), 2001, pp. 1408-1413
11. Keidar, S; Heinrich, R; Kaplan, M; Hayek, T; Aviram, M
    Angiotensin II administration to atherosclerotic mice increases macrophageuptake of oxidized LDL - A possible role for interleukin-6
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    S. Keidar et al., "Angiotensin II administration to atherosclerotic mice increases macrophageuptake of oxidized LDL - A possible role for interleukin-6", ART THROM V, 21(9), 2001, pp. 1464-1469
12. Heinecke, JW
    Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    J.W. Heinecke, "Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis", ART THROM V, 21(8), 2001, pp. 1261-1264
13. Husemann, J; Obstfeld, A; Febbraio, M; Kodama, T; Silverstein, SC
    CD11b/CD18 mediates production of reactive oxygen species by mouse and human macrophages adherent to matrixes containing oxidized LDL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    J. Husemann et al., "CD11b/CD18 mediates production of reactive oxygen species by mouse and human macrophages adherent to matrixes containing oxidized LDL", ART THROM V, 21(8), 2001, pp. 1301-1305
14. Nakayama, M; Takahashi, K; Komaru, T; Fukuchi, M; Shioiri, H; Sato, K; Kitamuro, T; Shirato, K; Yamaguchi, T; Suematsu, M; Shibahara, S
    Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    M. Nakayama et al., "Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions", ART THROM V, 21(8), 2001, pp. 1373-1377
15. Li, W; Dalen, H; Eaton, JW; Yuan, XM
    Apoptotic death of inflammatory cells in human atheroma
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    W. Li et al., "Apoptotic death of inflammatory cells in human atheroma", ART THROM V, 21(7), 2001, pp. 1124-1130
16. Laurila, A; Cole, SP; Merat, S; Obonyo, M; Palinski, W; Fierer, J; Witztum, JL
    High-fat, high-cholesterol diet increases the incidence of gastritis in LDL receptor-negative mice
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    A. Laurila et al., "High-fat, high-cholesterol diet increases the incidence of gastritis in LDL receptor-negative mice", ART THROM V, 21(6), 2001, pp. 991-996
17. McCall, MR; Carr, AC; Forte, TM; Frei, B
    LDL modified by hypochlorous acid is a potent inhibitor of lecithin-cholesterol acyltransferase activity
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    M.R. McCall et al., "LDL modified by hypochlorous acid is a potent inhibitor of lecithin-cholesterol acyltransferase activity", ART THROM V, 21(6), 2001, pp. 1040-1045
18. Kuzuya, M; Ramos, MA; Kanda, S; Koike, T; Asai, T; Maeda, K; Shitara, K; Shibuya, M; Iguchi, A
    VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    M. Kuzuya et al., "VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor", ART THROM V, 21(5), 2001, pp. 765-770
19. Glass, CK
    Antiatherogenic effects of thiazolidinediones?
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    C.K. Glass, "Antiatherogenic effects of thiazolidinediones?", ART THROM V, 21(3), 2001, pp. 295-296
20. Chen, Z; Ishibashi, S; Perrey, S; Osuga, J; Gotoda, T; Kitamine, T; Tamura, Y; Okazaki, H; Yahagi, N; Iizuka, Y; Shionoiri, F; Ohashi, K; Harada, K; Shimano, H; Nagai, R; Yamada, N
    Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice - Pleiotropic effects on CD36 expression and HDL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    Z. Chen et al., "Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice - Pleiotropic effects on CD36 expression and HDL", ART THROM V, 21(3), 2001, pp. 372-377
21. Kaplan, M; Aviram, M
    Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages - An alternative approach to study lipoproteins cellular uptake
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    M. Kaplan e M. Aviram, "Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages - An alternative approach to study lipoproteins cellular uptake", ART THROM V, 21(3), 2001, pp. 386-393
22. Meilhac, O; Ramachandran, S; Chiang, K; Santanam, N; Parthasarathy, S
    Role of arterial wall antioxidant defense in beneficial effects of exercise on atherosclerosis in mice
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    O. Meilhac et al., "Role of arterial wall antioxidant defense in beneficial effects of exercise on atherosclerosis in mice", ART THROM V, 21(10), 2001, pp. 1681-1688
23. Hulthe, J; Bokemark, L; Fagerberg, B
    Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    J. Hulthe et al., "Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men", ART THROM V, 21(1), 2001, pp. 101-107
24. Zhou, XH; Caligiuri, G; Hamsten, A; Lefvert, AK; Hansson, GK
    LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    X.H. Zhou et al., "LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis", ART THROM V, 21(1), 2001, pp. 108-114
25. Griffin, E; Re, A; Hamel, N; Fu, CZ; Bush, H; McCaffrey, T; Asch, AS
    A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation
    NATURE MEDICINE
    
    E. Griffin et al., "A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation", NAT MED, 7(7), 2001, pp. 842-848
26. Makowski, L; Boord, JB; Maeda, K; Babaev, VR; Uysal, KT; Morgan, MA; Parker, RA; Suttles, J; Fazio, S; Hotamisligil, GS; Linton, MF
    Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
    NATURE MEDICINE
    
    L. Makowski et al., "Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis", NAT MED, 7(6), 2001, pp. 699-705
27. Lazar, MA
    Progress in cardiovascular biology: PPAR for the course
    NATURE MEDICINE
    
    M.A. Lazar, "Progress in cardiovascular biology: PPAR for the course", NAT MED, 7(1), 2001, pp. 23-24
28. Moore, KJ; Rosen, ED; Fitzgerald, ML; Randow, F; Andersson, LP; Altshuler, D; Milstone, DS; Mortensen, RM; Spiegelman, BM; Freeman, MW
    The role of PPAR-gamma in macrophage differentiation and cholesterol uptake
    NATURE MEDICINE
    
    K.J. Moore et al., "The role of PPAR-gamma in macrophage differentiation and cholesterol uptake", NAT MED, 7(1), 2001, pp. 41-47
29. Chawla, A; Barak, Y; Nagy, L; Liao, D; Tontonoz, P; Evans, RM
    PPAR-gamma dependent and independent effects on macrophage-gene expressionin lipid metabolism and inflammation
    NATURE MEDICINE
    
    A. Chawla et al., "PPAR-gamma dependent and independent effects on macrophage-gene expressionin lipid metabolism and inflammation", NAT MED, 7(1), 2001, pp. 48-52
30. Han, SW; Greene, ME; Pitts, J; Wada, RK; Sidell, N
    Novel expression and function of peroxisome proliferator-activated receptor gamma (PPAR gamma) in human neuroblastoma cells
    CLINICAL CANCER RESEARCH
    
    S.W. Han et al., "Novel expression and function of peroxisome proliferator-activated receptor gamma (PPAR gamma) in human neuroblastoma cells", CLIN CANC R, 7(1), 2001, pp. 98-104
31. Witztum, JL; Steinberg, D
    The oxidative modification hypothesis of atherosclerosis: Does it hold forhumans?
    TRENDS IN CARDIOVASCULAR MEDICINE
    
    J.L. Witztum e D. Steinberg, "The oxidative modification hypothesis of atherosclerosis: Does it hold forhumans?", TREND CARD, 11(3-4), 2001, pp. 93-102
32. Stulak, JM; Lerman, A; Porcel, MR; Caccitolo, JA; Romero, JC; Schaff, HV; Napoli, C; Lerman, LO
    Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    J.M. Stulak et al., "Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation", J AM S NEPH, 12(9), 2001, pp. 1882-1891
33. Zima, T; Fialova, L; Mestek, O; Janebova, M; Crkovska, J; Malbohan, I; Stipek, S; Mikulikova, L; Popov, P
    Oxidative stress, metabolism of ethanol and alcohol-related diseases
    JOURNAL OF BIOMEDICAL SCIENCE
    
    T. Zima et al., "Oxidative stress, metabolism of ethanol and alcohol-related diseases", J BIOMED SC, 8(1), 2001, pp. 59-70
34. Bansal, G; Singh, U; Bansal, MP
    Effect of 7 beta-hydroxycholesterol on cellular redox status and heat shock protein 70 expression in macrophages
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
    
    G. Bansal et al., "Effect of 7 beta-hydroxycholesterol on cellular redox status and heat shock protein 70 expression in macrophages", CELL PHYS B, 11(5), 2001, pp. 241-246
35. Linton, MF; Fazio, S
    Class A scavenger receptors, macrophages, and atherosclerosis
    CURRENT OPINION IN LIPIDOLOGY
    
    M.F. Linton e S. Fazio, "Class A scavenger receptors, macrophages, and atherosclerosis", CURR OP LIP, 12(5), 2001, pp. 489-495
36. Plutzky, J
    Peroxisome proliferator-activated receptors in endothelial cell biology
    CURRENT OPINION IN LIPIDOLOGY
    
    J. Plutzky, "Peroxisome proliferator-activated receptors in endothelial cell biology", CURR OP LIP, 12(5), 2001, pp. 511-518
37. Moore, KJ; Fitzgerald, ML; Freeman, MW
    Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?
    CURRENT OPINION IN LIPIDOLOGY
    
    K.J. Moore et al., "Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?", CURR OP LIP, 12(5), 2001, pp. 519-527
38. Panini, SR; Sinensky, MS
    Mechanisms of oxysterol-induced apoptosis
    CURRENT OPINION IN LIPIDOLOGY
    
    S.R. Panini e M.S. Sinensky, "Mechanisms of oxysterol-induced apoptosis", CURR OP LIP, 12(5), 2001, pp. 529-533
39. Olinescu, RM; Kummerow, FA
    Fibrinogen is an efficient antioxidant
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY
    
    R.M. Olinescu e F.A. Kummerow, "Fibrinogen is an efficient antioxidant", J NUTR BIOC, 12(3), 2001, pp. 162-169
40. Kummerow, FA; Cook, LS; Wasowicz, E; Jelen, H
    Changes in the phospholipid composition of the arterial cell can result insevere atherosclerotic lesions
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY
    
    F.A. Kummerow et al., "Changes in the phospholipid composition of the arterial cell can result insevere atherosclerotic lesions", J NUTR BIOC, 12(10), 2001, pp. 602-607
41. Skyrme-Jones, RAP; Meredith, IT
    Soluble adhesion molecules, endothelial function and vitamin E in type 1 diabetes
    CORONARY ARTERY DISEASE
    
    R.A.P. Skyrme-Jones e I.T. Meredith, "Soluble adhesion molecules, endothelial function and vitamin E in type 1 diabetes", CORON ART D, 12(1), 2001, pp. 69-75
42. Sherer, Y; Bitzur, R; Cohen, H; Shaish, A; Varon, D; Shoenfeld, Y; Harats, D
    Mechanisms of action of the anti-atherogenic effect of magnesium: lessons from a mouse model
    MAGNESIUM RESEARCH
    
    Y. Sherer et al., "Mechanisms of action of the anti-atherogenic effect of magnesium: lessons from a mouse model", MAGNES RES, 14(3), 2001, pp. 173-179
43. Bobryshev, YV; Lord, RSA; Golovanova, NK; Gracheva, EV; Zvezdina, ND; Prokazova, NV
    Phenotype determination of anti-GM3 positive cells in atherosclerotic lesions of the human aorta - Hypothetical role of ganglioside GM3 in foam cell formation
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    
    Y.V. Bobryshev et al., "Phenotype determination of anti-GM3 positive cells in atherosclerotic lesions of the human aorta - Hypothetical role of ganglioside GM3 in foam cell formation", BBA-MOL BAS, 1535(2), 2001, pp. 87-99
44. Kaneko, T; Baba, N; Matsuo, M
    Structure-activity relationship of antioxidants for inhibitors of linoleicacid hydroperoxide-induced toxicity in cultured human umbilical vein endothelial cells
    CYTOTECHNOLOGY
    
    T. Kaneko et al., "Structure-activity relationship of antioxidants for inhibitors of linoleicacid hydroperoxide-induced toxicity in cultured human umbilical vein endothelial cells", CYTOTECHNOL, 35(1), 2001, pp. 43-55
45. Ozbey, N; Aydin, A; Telci, A; Cakatay, U
    Antibodies against oxidised low-density lipoprotein in hypopituitary patients with growth hormone deficiency
    ENDOCRINE JOURNAL
    
    N. Ozbey et al., "Antibodies against oxidised low-density lipoprotein in hypopituitary patients with growth hormone deficiency", ENDOCR J, 48(5), 2001, pp. 579-584
46. Howlader, ZH; Kamiyama, S; Murakami, Y; Ito, M; Komai, M; Furukawa, Y
    Lecithin : cholesterol acyltransferase reduces the adverse effects of oxidized low-density lipoprotein while incurring damage itself
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    
    Z.H. Howlader et al., "Lecithin : cholesterol acyltransferase reduces the adverse effects of oxidized low-density lipoprotein while incurring damage itself", BIOS BIOT B, 65(11), 2001, pp. 2496-2503
47. Camilletti, A; Moretti, N; Giacchetti, G; Faloia, E; Martarelli, D; Mantero, F; Mazzanti, L
    Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients
    AMERICAN JOURNAL OF HYPERTENSION
    
    A. Camilletti et al., "Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients", AM J HYPERT, 14(4), 2001, pp. 382-386
48. Vasile, E; Tomita, Y; Brown, LF; Kocher, O; Dvorak, HF
    Differential expression of thymosin beta-10 by early passage and senescentvascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis
    FASEB JOURNAL
    
    E. Vasile et al., "Differential expression of thymosin beta-10 by early passage and senescentvascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis", FASEB J, 15(2), 2001, pp. 458-466
49. Schwenke, DC; Behr, SR
    alpha-tocopherol and probucol reduce autoantibody titer to MDA-LDL in hypercholesterolemic rabbits
    FREE RADICAL BIOLOGY AND MEDICINE
    
    D.C. Schwenke e S.R. Behr, "alpha-tocopherol and probucol reduce autoantibody titer to MDA-LDL in hypercholesterolemic rabbits", FREE RAD B, 31(6), 2001, pp. 778-789
50. Nishinaka, T; Yabe-Nishimura, C
    EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress
    FREE RADICAL BIOLOGY AND MEDICINE
    
    T. Nishinaka e C. Yabe-Nishimura, "EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress", FREE RAD B, 31(2), 2001, pp. 205-216
51. Maziere, C; Conte, MA; Maziere, JC
    Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein
    FREE RADICAL BIOLOGY AND MEDICINE
    
    C. Maziere et al., "Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein", FREE RAD B, 31(11), 2001, pp. 1334-1340
52. Carr, AC; Decker, EA; Park, YJ; Frei, B
    Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acids
    FREE RADICAL BIOLOGY AND MEDICINE
    
    A.C. Carr et al., "Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acids", FREE RAD B, 31(1), 2001, pp. 62-72
53. Vay, D; Parodi, M; Rolla, R; Mottaran, E; Vidali, M; Bellomo, G; Albano, E
    Circulating antibodies recognizing malondialdehyde-modified proteins in healthy subjects
    FREE RADICAL BIOLOGY AND MEDICINE
    
    D. Vay et al., "Circulating antibodies recognizing malondialdehyde-modified proteins in healthy subjects", FREE RAD B, 30(3), 2001, pp. 277-286
54. Tselepis, A; Doulias, PT; Lourida, E; Glantzounis, G; Tsimoyiannis, E; Galaris, D
    Trimetazidine protects low-density lipoproteins from oxidation and cultured cells exposed to H2O2 from DNA damage
    FREE RADICAL BIOLOGY AND MEDICINE
    
    A. Tselepis et al., "Trimetazidine protects low-density lipoproteins from oxidation and cultured cells exposed to H2O2 from DNA damage", FREE RAD B, 30(12), 2001, pp. 1357-1364
55. Lestavel, S; Chinetti, G; Bocher, V; Fruchart, JC; Clavey, V; Staels, B
    Peroxisome proliferator-activated receptors in human atherosclerosis
    M S-MEDECINE SCIENCES
    
    S. Lestavel et al., "Peroxisome proliferator-activated receptors in human atherosclerosis", M S-MED SCI, 17(5), 2001, pp. 637-642
56. Wakatsuki, A; Okatani, Y; Ikenoue, N; Shinohara, K; Watanabe, K; Fukaya, T
    Melatonin protects against oxidized low-density lipoprotein-induced inhibition of nitric oxide production in human umbilical artery
    JOURNAL OF PINEAL RESEARCH
    
    A. Wakatsuki et al., "Melatonin protects against oxidized low-density lipoprotein-induced inhibition of nitric oxide production in human umbilical artery", J PINEAL R, 31(3), 2001, pp. 281-288
57. Napoli, C; de Nigris, F; Palinski, W
    Multiple role of reactive oxygen species in the arterial wall
    JOURNAL OF CELLULAR BIOCHEMISTRY
    
    C. Napoli et al., "Multiple role of reactive oxygen species in the arterial wall", J CELL BIOC, 82(4), 2001, pp. 674-682
58. Dar, P; Strassburger, D; Shaish, A; Levkovitz, H; Halperin, R; Harats, D
    Reduced reproduction with increased abortion rate in transgenic mice that overexpress 15-lipoxygenase
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    
    P. Dar et al., "Reduced reproduction with increased abortion rate in transgenic mice that overexpress 15-lipoxygenase", GYNECOL OBS, 52(1), 2001, pp. 18-21
59. Lee, TS; Chau, LY
    Fas/Fas ligand-mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    
    T.S. Lee e L.Y. Chau, "Fas/Fas ligand-mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells", AM J P-CELL, 280(3), 2001, pp. C709-C718
60. Egger, G; Burda, A; Obernosterer, A; Mitterhammer, H; Kager, G; Jurgens, G; Hofer, HP; Fabjan, JS; Pilger, E
    Blood polymorphonuclear leukocyte activation in atherosclerosis: Effects of aspirin
    INFLAMMATION
    
    G. Egger et al., "Blood polymorphonuclear leukocyte activation in atherosclerosis: Effects of aspirin", INFLAMMATIO, 25(2), 2001, pp. 129-135
61. Haberkorn, U; Bellemann, ME; Brix, G; Kamencic, H; Morr, I; Traut, U; Altmann, A; Doll, J; Blatter, J; Kinscherf, R
    Apoptosis and changes in glucose transport early after treatment of Morrishepatoma with gemcitabine
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    
    U. Haberkorn et al., "Apoptosis and changes in glucose transport early after treatment of Morrishepatoma with gemcitabine", EUR J NUCL, 28(4), 2001, pp. 418-425
62. Haberkorn, U; Altmann, A; Kamencic, H; Morr, I; Traut, U; Henze, M; Jiang, SM; Metz, J; Kinscherf, R
    Glucose transport and apoptosis after gene therapy with HSV thymidine kinase
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    
    U. Haberkorn et al., "Glucose transport and apoptosis after gene therapy with HSV thymidine kinase", EUR J NUCL, 28(11), 2001, pp. 1690-1696
63. Bron, D; Asmis, R
    Vitamin E and the prevention of atherosclerosis
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
    
    D. Bron e R. Asmis, "Vitamin E and the prevention of atherosclerosis", INT J VIT N, 71(1), 2001, pp. 18-24
64. Kaul, D
    Molecular link between cholesterol, cytokines and atherosclerosis
    MOLECULAR AND CELLULAR BIOCHEMISTRY
    
    D. Kaul, "Molecular link between cholesterol, cytokines and atherosclerosis", MOL C BIOCH, 219(1-2), 2001, pp. 65-71
65. Marx, N; Hombach, V
    Peroxisome proliferator-activated receptors (PPARs) in the vessels wall - new regulators of gene expression in vascular cells
    ZEITSCHRIFT FUR KARDIOLOGIE
    
    N. Marx e V. Hombach, "Peroxisome proliferator-activated receptors (PPARs) in the vessels wall - new regulators of gene expression in vascular cells", Z KARDIOL, 90(7), 2001, pp. 470-477
66. Uchimura, K; Nakamuta, M; Enjoji, M; Irie, T; Sugimoto, R; Muta, T; Iwamoto, H; Nawata, H
    Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells
    HEPATOLOGY
    
    K. Uchimura et al., "Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells", HEPATOLOGY, 33(1), 2001, pp. 91-99
67. Laffitte, BA; Joseph, SB; Walczak, R; Pei, LM; Wilpitz, DC; Collins, JL; Tontonoz, P
    Autoregulation of the human liver X receptor alpha promoter
    MOLECULAR AND CELLULAR BIOLOGY
    
    B.A. Laffitte et al., "Autoregulation of the human liver X receptor alpha promoter", MOL CELL B, 21(22), 2001, pp. 7558-7568
68. Tsoukatos, DC; Liapikos, TA; Tselepis, AD; Chapman, MJ; Ninio, E
    Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein
    BIOCHEMICAL JOURNAL
    
    D.C. Tsoukatos et al., "Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein", BIOCHEM J, 357, 2001, pp. 457-464
69. Chen, MY; Narumiya, S; Masaki, T; Sawamura, T
    Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding
    BIOCHEMICAL JOURNAL
    
    M.Y. Chen et al., "Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding", BIOCHEM J, 355, 2001, pp. 289-296
70. Zhang, L; Rui, YC; Qiu, Y; Li, TJ
    Effect of lysophosphatidylcholine on expression of vascular endothelial growth factor in ECV304 cells
    ACTA PHARMACOLOGICA SINICA
    
    L. Zhang et al., "Effect of lysophosphatidylcholine on expression of vascular endothelial growth factor in ECV304 cells", ACT PHAR SI, 22(4), 2001, pp. 335-339
71. Dzau, VJ
    Tissue angiotensin and pathobiology of vascular disease - A unifying hypothesis
    HYPERTENSION
    
    V.J. Dzau, "Tissue angiotensin and pathobiology of vascular disease - A unifying hypothesis", HYPERTENSIO, 37(4), 2001, pp. 1047-1052
72. Wu, RH; Lemne, C; de Faire, U; Frostegard, J
    Antibodies to lysophosphatidylcholine are decreased in borderline hypertension
    HYPERTENSION
    
    R.H. Wu et al., "Antibodies to lysophosphatidylcholine are decreased in borderline hypertension", HYPERTENSIO, 37(1), 2001, pp. 154-159
73. Ratcliffe, NR; Kennedy, SM; Morganelli, PM
    Immunocytochemical detection of Fc gamma receptors in human atherosclerotic lesions
    IMMUNOLOGY LETTERS
    
    N.R. Ratcliffe et al., "Immunocytochemical detection of Fc gamma receptors in human atherosclerotic lesions", IMMUNOL LET, 77(3), 2001, pp. 169-174
74. Dotevall, A; Hulthe, J; Rosengren, A; Wiklund, O; Wilhelmsen, L
    Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women
    CLINICAL SCIENCE
    
    A. Dotevall et al., "Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women", CLIN SCI, 101(5), 2001, pp. 523-531
75. Boullier, A; Hennuyer, N; Tailleux, A; Furman, C; Duverger, N; Caillaud, JM; Castro, G; Fievet, C; Fruchart, JC; Duriez, P
    Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-1 with severe hypercholesterolaemia
    CLINICAL SCIENCE
    
    A. Boullier et al., "Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-1 with severe hypercholesterolaemia", CLIN SCI, 100(3), 2001, pp. 343-355
76. Aitman, TJ
    CD36, insulin resistance, and coronary heart disease
    LANCET
    
    T.J. Aitman, "CD36, insulin resistance, and coronary heart disease", LANCET, 357(9257), 2001, pp. 651-652
77. Bosmans, JL; Holvoet, P; Dauwe, SEH; Ysebaert, DK; Chapelle, T; Jurgens, A; Kovacic, V; Van Marck, EA; De Broe, ME; Verpooten, GA
    Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years
    KIDNEY INTERNATIONAL
    
    J.L. Bosmans et al., "Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years", KIDNEY INT, 59(6), 2001, pp. 2346-2356
78. Chen, HC; Guh, JY; Shin, SJ; Tsai, JH; Lai, YH
    Insulin and heparin suppress superoxide production in diabetic rat glomeruli stimulated with low-density lipoprotein
    KIDNEY INTERNATIONAL
    
    H.C. Chen et al., "Insulin and heparin suppress superoxide production in diabetic rat glomeruli stimulated with low-density lipoprotein", KIDNEY INT, 59, 2001, pp. S124-S127
79. Spiteller, G
    Peroxidation of linoleic acid and its relation to aging and age dependent diseases
    MECHANISMS OF AGEING AND DEVELOPMENT
    
    G. Spiteller, "Peroxidation of linoleic acid and its relation to aging and age dependent diseases", MECH AGE D, 122(7), 2001, pp. 617-657
80. Fellstrom, B
    Nonimmune risk factors for chronic renal allograft disfunction
    TRANSPLANTATION
    
    B. Fellstrom, "Nonimmune risk factors for chronic renal allograft disfunction", TRANSPLANT, 71(11), 2001, pp. SS10-SS16
81. Rubba, P; Panico, S; Bond, MG; Covetti, G; Celentano, E; Iannuzzi, A; Galasso, R; Belisario, MA; Pastinese, A; Sacchetti, L; Mancini, M; Salvatore, F
    Site-specific atherosclerotic plaques in the carotid arteries of middle-aged women from southern Italy - Associations with traditional risk factors and oxidation markers
    STROKE
    
    P. Rubba et al., "Site-specific atherosclerotic plaques in the carotid arteries of middle-aged women from southern Italy - Associations with traditional risk factors and oxidation markers", STROKE, 32(9), 2001, pp. 1953-1959
82. Fukuchi, Y
    Interactions between Asp-hemolysin from Aspergillus fumigatus and blood plasma components
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    
    Y. Fukuchi, "Interactions between Asp-hemolysin from Aspergillus fumigatus and blood plasma components", YAKUGAKU ZA, 121(6), 2001, pp. 423-432
83. Skrzep-Poloczek, B; Tomasik, A; Tarnawski, R; Hyla-Klekot, L; Dyduch, A; Wojciechowska, C; Wesolowski, W; Kopieczna-Grzebieniak, E; Zalejska-Fiolka, J; Widera, E
    Nephrotic origin hyperlipidemia, relative reduction of vitamin E level andsubsequent oxidative stress may promote atherosclerosis
    NEPHRON
    
    B. Skrzep-Poloczek et al., "Nephrotic origin hyperlipidemia, relative reduction of vitamin E level andsubsequent oxidative stress may promote atherosclerosis", NEPHRON, 89(1), 2001, pp. 68-72
84. Claudel, T; Leibowitz, MD; Fievet, C; Tailleux, A; Wagner, B; Repa, JJ; Torpier, G; Lobaccaro, JM; Paterniti, JR; Mangelsdorf, DJ; Heyman, RA; Auwerx, J
    Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    T. Claudel et al., "Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor", P NAS US, 98(5), 2001, pp. 2610-2615
85. Klein, RL; Ascencao, JL; Mironova, M; Huang, Y; Lopes-Virella, MF
    Effect of inflammatory cytokines on the metabolism of low-density lipoproteins by human vascular endothelial cells
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    R.L. Klein et al., "Effect of inflammatory cytokines on the metabolism of low-density lipoproteins by human vascular endothelial cells", METABOLISM, 50(1), 2001, pp. 99-106
86. Paramo, JA; Orbe, J; Rodriguez, JA
    Antioxidants in the prevention of cardiovascular disease
    MEDICINA CLINICA
    
    J.A. Paramo et al., "Antioxidants in the prevention of cardiovascular disease", MED CLIN, 116(16), 2001, pp. 629-635
87. Wang, XS; Greilberger, J; Ratschek, M; Jurgens, G
    Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium
    JOURNAL OF PATHOLOGY
    
    X.S. Wang et al., "Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium", J PATHOLOGY, 195(2), 2001, pp. 244-250
88. Lau, BHS
    Suppression of LDL oxidation by garlic
    JOURNAL OF NUTRITION
    
    B.H.S. Lau, "Suppression of LDL oxidation by garlic", J NUTR, 131, 2001, pp. 985S-988S
89. Ide, N; Lau, BHS
    Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-kappa B activation
    JOURNAL OF NUTRITION
    
    N. Ide e B.H.S. Lau, "Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-kappa B activation", J NUTR, 131, 2001, pp. 1020S-1026S
90. Haug, C; Schmid-Kotsas, A; Zorn, U; Schuett, S; Gross, HJ; Gruenert, A; Bachem, MG
    Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    
    C. Haug et al., "Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins", J MOL CEL C, 33(9), 2001, pp. 1701-1712
91. Gillotte-Taylor, K; Boullier, A; Witztum, JL; Steinberg, D; Quehenberger, O
    Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein
    JOURNAL OF LIPID RESEARCH
    
    K. Gillotte-Taylor et al., "Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein", J LIPID RES, 42(9), 2001, pp. 1474-1482
92. de Villiers, WJS; Cai, L; Webb, NR; de Beer, MC; van der Westhuyzen, DR; de Beer, FC
    CD36 does not play a direct role in HDL or LDL metabolism
    JOURNAL OF LIPID RESEARCH
    
    W.J.S. de Villiers et al., "CD36 does not play a direct role in HDL or LDL metabolism", J LIPID RES, 42(8), 2001, pp. 1231-1238
93. Navab, M; Hama, SY; Hough, GP; Subbanagounder, G; Reddy, ST; Fogelman, AM
    A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids
    JOURNAL OF LIPID RESEARCH
    
    M. Navab et al., "A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids", J LIPID RES, 42(8), 2001, pp. 1308-1317
94. Devaraj, S; Hugou, I; Jialal, I
    alpha-Tocopherol decreases CD36 expression in human monocyte-derived macrophages
    JOURNAL OF LIPID RESEARCH
    
    S. Devaraj et al., "alpha-Tocopherol decreases CD36 expression in human monocyte-derived macrophages", J LIPID RES, 42(4), 2001, pp. 521-527
95. Maung, KK; Miyazaki, A; Nomiyama, H; Chang, CCY; Chang, TY; Horiuchi, S
    Induction of acyl-coenzyme A : cholesterol acyltransferase-1 by 1,25-dihydroxyvitamin D-3 or 9-cis-retinoic acid in undifferentiated THP-1 cells
    JOURNAL OF LIPID RESEARCH
    
    K.K. Maung et al., "Induction of acyl-coenzyme A : cholesterol acyltransferase-1 by 1,25-dihydroxyvitamin D-3 or 9-cis-retinoic acid in undifferentiated THP-1 cells", J LIPID RES, 42(2), 2001, pp. 181-187
96. Hsu, HC; Lee, YT; Yeh, HT; Chen, MF
    Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    
    H.C. Hsu et al., "Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia", J LA CL MED, 137(6), 2001, pp. 414-421
97. Shimaoka, T; Kume, N; Minami, M; Hayashida, K; Sawamura, T; Kita, T; Yonehara, S
    LOX-1 supports adhesion of gram-positive and gram-negative bacteria
    JOURNAL OF IMMUNOLOGY
    
    T. Shimaoka et al., "LOX-1 supports adhesion of gram-positive and gram-negative bacteria", J IMMUNOL, 166(8), 2001, pp. 5108-5114
98. Glass, CK
    Potential roles of the peroxisome proliferator-activated receptor-gamma inmacrophage biology and atherosclerosis
    JOURNAL OF ENDOCRINOLOGY
    
    C.K. Glass, "Potential roles of the peroxisome proliferator-activated receptor-gamma inmacrophage biology and atherosclerosis", J ENDOCR, 169(3), 2001, pp. 461-464
99. Schober, A; Bottner, M; Strelau, J; Kinscherf, R; Bonaterra, GA; Barth, M; Schilling, L; Fairlie, WD; Breit, SN; Unsicker, K
    Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain
    JOURNAL OF COMPARATIVE NEUROLOGY
    
    A. Schober et al., "Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain", J COMP NEUR, 439(1), 2001, pp. 32-45
100. Febbraio, M; Hajjar, DP; Silverstein, RL
     CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
     JOURNAL OF CLINICAL INVESTIGATION
     
     M. Febbraio et al., "CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism", J CLIN INV, 108(6), 2001, pp. 785-791